Literature DB >> 33271317

Effects of caloric restriction on immunosurveillance, microbiota and cancer cell phenotype: Possible implications for cancer treatment.

Francesca Pistollato1, Tamara Yuliett Forbes-Hernandez2, Ruben Calderón Iglesias1, Roberto Ruiz1, Maria Elexpuru Zabaleta1, Irma Dominguez3, Danila Cianciosi4, Josè L Quiles5, Francesca Giampieri6, Maurizio Battino7.   

Abstract

Fasting, caloric restriction and foods or compounds mimicking the biological effects of caloric restriction, known as caloric restriction mimetics, have been associated with a lower risk of age-related diseases, including cardiovascular diseases, cancer and cognitive decline, and a longer lifespan. Reduced calorie intake has been shown to stimulate cancer immunosurveillance, reducing the migration of immunosuppressive regulatory T cells towards the tumor bulk. Autophagy stimulation via reduction of lysine acetylation, increased sensitivity to chemo- and immunotherapy, along with a reduction of insulin-like growth factor 1 and reactive oxygen species have been described as some of the major effects triggered by caloric restriction. Fasting and caloric restriction have also been shown to beneficially influence gut microbiota composition, modify host metabolism, reduce total cholesterol and triglyceride levels, lower diastolic blood pressure and elevate morning cortisol level, with beneficial modulatory effects on cardiopulmonary fitness, body fat and weight, fatigue and weakness, and general quality of life. Moreover, caloric restriction may reduce the carcinogenic and metastatic potential of cancer stem cells, which are generally considered responsible of tumor formation and relapse. Here, we reviewed in vitro and in vivo studies describing the effects of fasting, caloric restriction and some caloric restriction mimetics on immunosurveillance, gut microbiota, metabolism, and cancer stem cell growth, highlighting the molecular and cellular mechanisms underlying these effects. Additionally, studies on caloric restriction interventions in cancer patients or cancer risk subjects are discussed. Considering the promising effects associated with caloric restriction and caloric restriction mimetics, we think that controlled-randomized large clinical trials are warranted to evaluate the inclusion of these non-pharmacological approaches in clinical practice.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autophagy; Caloric restriction; Cancer stem cells; Fasting; Gut microbiota; Immune system

Mesh:

Year:  2020        PMID: 33271317     DOI: 10.1016/j.semcancer.2020.11.017

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  4 in total

1.  Nutritional Support in Cancer patients: update of the Italian Intersociety Working Group practical recommendations.

Authors:  Riccardo Caccialanza; Paolo Cotogni; Emanuele Cereda; Paolo Bossi; Giuseppe Aprile; Paolo Delrio; Patrizia Gnagnarella; Annalisa Mascheroni; Taira Monge; Ettore Corradi; Michele Grieco; Sergio Riso; Francesco De Lorenzo; Francesca Traclò; Elisabetta Iannelli; Giordano Domenico Beretta; Michela Zanetti; Saverio Cinieri; Vittorina Zagonel; Paolo Pedrazzoli
Journal:  J Cancer       Date:  2022-05-21       Impact factor: 4.478

Review 2.  The Clinical Value of Nutritional Care before and during Active Cancer Treatment.

Authors:  Giuseppe Aprile; Debora Basile; Renato Giaretta; Gessica Schiavo; Nicla La Verde; Ettore Corradi; Taira Monge; Francesco Agustoni; Silvia Stragliotto
Journal:  Nutrients       Date:  2021-04-05       Impact factor: 5.717

Review 3.  Role of Diet in Stem and Cancer Stem Cells.

Authors:  Francesca Puca; Monica Fedele; Debora Rasio; Sabrina Battista
Journal:  Int J Mol Sci       Date:  2022-07-23       Impact factor: 6.208

Review 4.  Pleiotropic Effects of Glucocorticoids on the Immune System in Circadian Rhythm and Stress.

Authors:  Akihiro Shimba; Aki Ejima; Koichi Ikuta
Journal:  Front Immunol       Date:  2021-10-08       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.